blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2178553

EP2178553 - USE OF A GRANULIN OR A GRANULIN-LIKE COMPOUND IN THE THERAPY OR PROPHYLAXIS OF CHRONIC PAINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.10.2014
Database last updated on 03.08.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Johann Wolfgang Goethe-Universität Frankfurt am Main
Senckenberganlage 31
60325 Frankfurt am Main / DE
[2010/17]
Inventor(s)01 / TEGEDER, Irmgard
Darmstädter Landstrasse 324
60598 Frankfurt / DE
02 / GEISSLINGER, Gerd
Drei Lindenstrasse 31
65812 Bad Soden / DE
 [2010/17]
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[N/P]
Former [2013/48]Krauss, Jan
Boehmert & Boehmert
Pettenkoferstrasse 20-22
80336 München / DE
Former [2010/17]Krauss, Jan
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date08784323.114.07.2008
[2010/17]
WO2008DE01138
Priority number, dateDE2007103335916.07.2007         Original published format: DE102007033359
[2010/17]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2009010045
Date:22.01.2009
Language:DE
[2009/04]
Type: A1 Application with search report 
No.:EP2178553
Date:28.04.2010
Language:DE
The application published by WIPO in one of the EPO official languages on 22.01.2009 takes the place of the publication of the European patent application.
[2010/17]
Type: B1 Patent specification 
No.:EP2178553
Date:27.11.2013
Language:DE
[2013/48]
Search report(s)International search report - published on:EP22.01.2009
ClassificationIPC:A61K38/17, A61P25/02
[2013/26]
CPC:
A61K38/17 (EP,US); A61K38/1709 (EP,US); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P43/00 (EP) (-)
Former IPC [2010/17]A61K38/18, A61P25/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/17]
TitleGerman:VERWENDUNG EINES GRANULINS ODER EINER GRANULIN-ÄHNLICHEN VERBINDUNG ZUR THERAPIE ODER PROPHYLAXE VON CHRONISCHEN SCHMERZEN[2010/17]
English:USE OF A GRANULIN OR A GRANULIN-LIKE COMPOUND IN THE THERAPY OR PROPHYLAXIS OF CHRONIC PAINS[2010/17]
French:UTILISATION D'UNE GRANULINE OU D'UN COMPOSÉ ANALOGUE À LA GRANULINE POUR LA THÉRAPIE OU LA PROPHYLAXIE DES DOULEURS CHRONIQUES[2010/17]
Entry into regional phase12.02.2010National basic fee paid 
12.02.2010Designation fee(s) paid 
12.02.2010Examination fee paid 
Examination procedure12.02.2010Examination requested  [2010/17]
18.06.2013Communication of intention to grant the patent
14.10.2013Fee for grant paid
14.10.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.06.2013
Opposition(s)28.08.2014No opposition filed within time limit [2014/45]
Fees paidRenewal fee
14.07.2010Renewal fee patent year 03
12.07.2011Renewal fee patent year 04
13.07.2012Renewal fee patent year 05
10.07.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.07.2008
BG27.11.2013
CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
MC27.11.2013
MT27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
TR27.11.2013
NO27.02.2014
GR28.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
BE31.07.2014
CH31.07.2014
LI31.07.2014
[2016/33]
Former [2016/32]HU14.07.2008
BG27.11.2013
CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
MC27.11.2013
MT27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
GR28.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
BE31.07.2014
CH31.07.2014
LI31.07.2014
Former [2016/28]BG27.11.2013
CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
MC27.11.2013
MT27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
GR28.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2016/25]BG27.11.2013
CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
MC27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2016/21]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
MC27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2015/51]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
AT14.07.2014
IE14.07.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2015/37]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
IE14.07.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2015/22]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
IT27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2015/20]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
LU14.07.2014
CH31.07.2014
LI31.07.2014
Former [2015/14]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SI27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
LU14.07.2014
Former [2015/13]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
LU14.07.2014
Former [2014/41]CY27.11.2013
CZ27.11.2013
DK27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
Former [2014/37]CY27.11.2013
CZ27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
PL27.11.2013
RO27.11.2013
SE27.11.2013
SK27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
Former [2014/36]CY27.11.2013
EE27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
Former [2014/28]CY27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
PT27.03.2014
Former [2014/26]CY27.11.2013
ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
Former [2014/25]ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
LV27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
Former [2014/24]ES27.11.2013
FI27.11.2013
HR27.11.2013
LT27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
Former [2014/23]FI27.11.2013
HR27.11.2013
LT27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
IS27.03.2014
Former [2014/22]FI27.11.2013
LT27.11.2013
NL27.11.2013
SE27.11.2013
NO27.02.2014
Former [2014/20]LT27.11.2013
NO27.02.2014
Cited inInternational search[PX]WO2008019187  (MAYO FOUNDATION [US], et al) [PX] 8-13 * claim 61; sequences 1,78-84 *;
 [X]WO9315195  (SOLOMON SAMUEL [CA]) [X] 8-13 * page 22, line 31 - page 23, line 9; figure 4c; claims 1-14 *;
 [X]WO2007000924  (UNIV OSAKA [JP], et al) [X] 8-13 * abstract *;
 [X]WO2004078782  (A & G PHARMACEUTICALS INC [US], et al) [X] 8,9,11,13 * paragraph [0021] *;
 [X]EP1164144  (AJINMOTO CO INC [JP]) [X] 8-13 * sequences 3-7 *;
 [A]  - WANG W ET AL, "PC cell-derived growth factor (Granulin precursor) expression and action in human multiple myeloma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20030601), vol. 9, ISSN 1078-0432, pages 2221 - 2228, XP002977715 [A] 1-13 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.